for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Baxter International ‍announces commercial launch of new indication for oXiris set​

Sept 26 (Reuters) - Baxter International Inc :

* Baxter launches first 3-in-1 set for use in continuous renal replacement therapy and sepsis management protocols

* Baxter International Inc - announced commercial launch of a new indication for company’s oXiris set

* Baxter International Inc - Baxter currently plans to file for expanded indication for oXiris set in additional countries in 2018 and beyond Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up